First Trust Investment Solutions L.P. Gilead Sciences, Inc. Transaction History
First Trust Investment Solutions L.P.
- $568 Billion
- Q1 2024
A detailed history of First Trust Investment Solutions L.P. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Trust Investment Solutions L.P. holds 10,916 shares of GILD stock, worth $737,375. This represents 0.14% of its overall portfolio holdings.
Number of Shares
10,916
Previous 15,471
29.44%
Holding current value
$737,375
Previous $1.25 Billion
36.2%
% of portfolio
0.14%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
1,885Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.28 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.75 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.71 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.14 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.9 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $84.7B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...